PLEXXIKON CHOOSES SUN MICROSYSTEMS AND SUN GRID TECHNOLOGY TO POWER INNOVATIVE DRUG DISCOVERY PLATFORM

6/10/2002 - Sun Microsystems, Inc., a leader in systems and solutions that make the Net work, and Plexxikon, a drug discovery company, announced today that Sun has been selected by Plexxikon as its strategic technology partner, providing the life sciences company with an end-to-end IT solution to help drive Plexxikon's efforts to discover drugs faster, better and at a lower cost. "Our drug discovery platform is based on highly integrated technologies that incorporate a heavy computational element. Sun's Grid Engine technology allows us to more efficiently utilize the various technologies and applications needed to power that platform," said Dr. Michael Milburn, senior vice president of research, Plexxikon. "We chose Sun not only because of the company's reputation for support, reliability and technical expertise, but also because of its commitment to investment in the life sciences, which is particularly critical as companies like Plexxikon integrate computation as a significant part of their platforms."

Previous Page | News by Category | News Search

If you found this page useful, bookmark and share it on: